Friday, February 1, 2019

Many of the largest U.S. pharmacies and drug distributors do not have Teva Pharmaceutical Industries Ltd's generic version of the life-saving EpiPen allergy treatment five months after it was approved for sale in the United States, pharmacy chains and a group that tracks drug shortages told Reuters.


from Reuters: Health News https://reut.rs/2BbMWko

Related Posts:

  • LATEST HEALTH NEWSActivists have hailed this move saying it will be helpful in implementing the laws to curtail tobacco use from Health https://ift.tt/2OTmGUN … Read More
  • LATEST HEALTH NEWSCurrently, the Health Ministry has three common applications in use across the country at Health and Wellness Centers -- for Reproductive Child Health (RCH), Non-Communicable Diseases (NCD) and TB from Health https://ift.tt/… Read More
  • LATEST HEALTH NEWSThe private sector handles an estimated two-thirds of India's 2.74 million new TB cases--the highest TB burden in the world from Health https://ift.tt/2pXqOV1 … Read More
  • LATEST HEALTH NEWSThe state Health department Thursday also released guidelines for the treatment of swine flu patients from Health https://ift.tt/2qdpr4C … Read More
  • LATEST HEALTH NEWSRepublicans could try again to repeal Obamacare if they win enough seats in U.S. elections next month, Senate Republican Leader Mitch McConnell said on Wednesday, calling a failed 2017 push to repeal the healthcare law a "dis… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner